Press Room

Article / Jun 19, 2014

Scale-up & QbD Approaches for Spray-Dried Inhalation Formulations

ONdrugDelivery, 2014, June, pp. 3 - 8

Here, Eunice Costa, PhD, Scientist, Drug Product Development; Filipe Neves, PhD, Senior Scientist, Group Leader, Drug Product Development; Gonçalo Andrade, PhD, Business Development Manager; and Conrad Winters, PhD, Director, Drug Product Development, all of Hovione, describe the strong position of inhalable products in preclinical and clinical pipelines and make the case for formulation-based approaches to enable and enhance pulmonary product development.
Spray-drying technology in particular is highlighted as a highly favourable, scalable manufacturing technique for inhalable composite particles.


Read article here

Also in the Press Room

Press Release / Mar 07, 2018

Hovione sells the iMAX business

Hovione announces that it has concluded the sale of all of the share capital of iMAX Diagnostic Imaging limited.